Tenapanor safety study for teens with constipation-predominant IBS
Treatments studied
Part of Digestive system clinical trials.
This trial checks the safety of tenapanor in children and teens (ages 6 to under 18) with IBS-C. It is only for people who finished a previous related study and agreed to continue follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 6 and under 18 years old when you enroll
- You must have finished the earlier (parent) study right before this one and followed the study plan well
- If you could become pregnant, you must have a negative pregnancy test at the end of the parent study and use birth control (or not have sex)
- You need to be able to move around on your own (ambulatory)
- A parent/guardian must give permission, and you (the child) must be willing to follow the study rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called tenapanor for people with chronic idiopathic constipation (constipation with no clear cause). It aims to see if the drug can safely improve bowel movements in adults.
This study tests whether a medication called tenapanor can help relieve constipation in people with Parkinson's disease. If you have Parkinson's and have been struggling with constipation for at least 6 months, this trial may offer a new option to improve bowel regularity.
This study tests a new medicine called plecanatide for children and teens with functional constipation. It aims to see if it helps improve bowel movements compared to a placebo (a pill with no medicine).
This study tests whether adding a medication called tenapanor (which helps reduce phosphorus absorption in the gut) to your current phosphate binder can improve blood phosphorus levels in people on hemodialysis. It aims to find a safe and effective way to lower phosphorus, which is important for bone and heart health.
This trial tests a new medicine called IN-114199 in healthy people to see if it is safe and how the body handles it. It is a first-in-human study, meaning it is the first time this drug is given to people.
This trial tests whether an oral medicine (eluxadoline) can help children and teens with IBS-D, a condition that causes stomach pain and frequent loose stools. It’s a Phase 3 study, meaning it’s designed to confirm benefits and safety.
Hear when a new Irritable Bowel Syndrome With Constipation (IBS-C) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.